Condition
Isotretinoin Adverse Reaction
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation2
Completed1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07296536Enrolling By Invitation
Expert Consensus on the Use of Isotretinoin in Rejuvenation: A Delphi Study
NCT07296523Enrolling By Invitation
Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study
NCT07196787Not ApplicableRecruiting
Exercise Therapy for Isotretinoin Users
NCT04663906UnknownPrimary
Oral Isotretinoin and Covid-19 Infection
NCT04204304Not ApplicableCompleted
Relationship Between Serum Vitamin D Levels and Musculoskeletal Adverse Effects in Patients Using Isotretinoin
Showing all 5 trials